Shenxiong Glucose Injection Protects H9c2 Cells From CoCl 2 -Induced Oxidative Damage via Antioxidant and Antiapoptotic Pathways

作者：Ding-Yan Lu, Yubin Zhang, Wei-Na Xue, Jia Sun, Chang Yang, Changhu Lin, Yongjun Li, Ting Liu · 发表于：Natural Product Communications · 年份：2020 · DOI：10.1177/1934578x20920054 · 被引用次数：1 · 研究领域：Traditional Chinese Medicine Analysis、Flavonoids in Medical Research、Neurological Disease Mechanisms and Treatments

Cardiovascular disease has become one of the main diseases that endanger humans, and oxidative damage plays an important role in this. Shenxiong glucose injection (SGI) is a common clinical treatment in China for the treatment of this condition. To understand further the protective effects and related mechanisms of SGI on cardiovascular diseases, H9c2 cells were treated with SGI at different concentrations (0.5%, 1%, 2% [v/v]) before hypoxic damage was induced by treatment with CoCl 2 ). In CoCl 2 -induced H9c2 cells, SGI treatment increased cell viability and the activity of superoxide dismutase, glutathione peroxidase, catalase, elevated mitochondrial membrane potential, and decreased the rate of cellular apoptosis, lactic dehydrogenase release, and the content of malondialdehyde and reactive oxygen species, while also upregulating Bcl-2 expression and downregulating Bax, Cyt-c, and cleaved caspase-3 expression. Together, these results suggested that SGI has a protective effect on CoCl 2 -induced damage, and its mechanism may be related to increased antioxidant and antiapoptosis capacity in H9c2 cells. This study provides the basis for further research and potential practical applications of SGI.